Fei Li
- Hematology top 1%
- Molecular Biology
- Cancer Research top 5%
- Immunology top 10%
- Oncology top 10%
- Topics
- Lymphoma Diagnosis and Treatment (25 papers)Multiple Myeloma Research and Treatments (18 papers)Hematopoietic Stem Cell Transplantation (17 papers)
- Cited by
- HematologyCancer ResearchImmunology
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Fei Li
132 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 99
- Hematology 648
- Molecular Biology 546
- Cancer Research 366
- Immunology 344
- Oncology 269
Countries citing papers authored by Fei Li
This map shows the geographic impact of Fei Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Li more than expected).
Fields of papers citing papers by Fei Li
This network shows the impact of papers produced by Fei Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Li. The network helps show where Fei Li may publish in the future.
Co-authorship network of co-authors of Fei Li
This figure shows the co-authorship network connecting the top 25 collaborators of Fei Li. A scholar is included among the top collaborators of Fei Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fei Li. Fei Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 3 | |
| 3 | 7 | |
| 4 | 1 | |
| 5 | 1 | |
| 6 | 4 | |
| 7 | 7 | |
| 8 | 0 | |
| 9 | 2 | |
| 10 | 8 | |
| 11 | 7 | |
| 12 | 8 | |
| 13 | 100 | |
| 14 | 1 | |
| 15 | 41 | |
| 16 | 22 | |
| 17 | 2 | |
| 18 | A novel missense mutation of bovine lipase maturation factor 1 (LMF1) gene and its association with growth traits | 2 |
| 19 | 16 | |
| 20 | 1 |
About Fei Li
Fei Li is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine, having authored 146 papers that have together received 1.5k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (25 papers), Multiple Myeloma Research and Treatments (18 papers) and Hematopoietic Stem Cell Transplantation (17 papers). The work is most often cited by research in Hematology (648 citations), Cancer Research (366 citations) and Immunology (344 citations). Fei Li has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Mu Hao, Ye Yang, Lugui Qiu, Yan Xu, Lugui Qiu, Hong Chang, Jahangir Abdi, Yijun Yang, Manujendra N. Saha and Pu Li. Their work appears in journals such as Circulation, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.